Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - imidacloprid; permethrin; n-methylpyrrolidone - topical solution/suspension - imidacloprid guanidine active 100.0 g/l; permethrin pyrethroid active 500.0 g/l; n-methylpyrrolidone solvent other 484.0 g/l - parasiticides - dog - puppy | dog - up to 4kg - brown dog tick | brown house mosquito | bush tick | common australian mosquito | dengue mosquito | dogbiting louse | dogsucking louse | flea | midges & sandflies - culicoides spp. | paralysis tick | stable fly | australian paralysis tick | ctenocephalides spp. | dog tick | ground fleas | new zealand cattle tick | scrub tick

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - ivermectin - oral paste - ivermectin anthelmintic active 18.7 g/kg - parasiticides - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - bots - gasterophilus spp. | cutaneous onchocerciasis | draschia spp. | habronema spp. | intestinal threadworm - s. westeri | large mouth stomach worm | large roundworm - parascaris equorum | large strongyles - strongylus edentatus | large strongyles - strongylus equinus | large strongyles - strongylus vulgaris | large strongyles - triodontophorus spp. | lungworm - dictyocaulus arnfieldi | neck threadworm | pinworm - oxyuris equi | small strongyles - cyathostomum spp. | small strongyles - cylicocyclus spp. | small strongyles - cylicodontophorus spp | small strongyles - cylicostephanus spp. | small strongyles - gyalocephalus spp. | stomach hair worm | bloodworm | bot fly | bot fly - oral and gastric sta | cutaneous onchocerciasis | gasterophilus haemorrhoidalis | gasterophilus inermis | gasterophilus intestinalis | gasterophilus nasalis | gasterophilus pecorum | large white roundworm | red worm | stomach bot | summer sores

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - cloprostenol as the sodium salt - parenteral liquid/solution/suspension - cloprostenol as the sodium salt prostaglandin active 250.0 ug/ml - endocrine system - cattle | horse | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | colt | cow | dairy cow | donkey | - bovine oestrus cycle | equine oestrus cycle | sex hormones | abortion | anoestrus | controlled breeding | ctrl of oestrus rel.behaviour | luteolytic agent | oestrus control | oestrus induction

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

viatris limited - danazol 100mg - capsule - 100 mg - active: danazol 100mg excipient: colloidal silicon dioxide gelatin   iron oxide black   lactose lactose monohydrate magnesium stearate microcrystalline cellulose povidone sodium laurilsulfate sodium starch glycolate tekprint black sw-9008 titanium dioxide   - endometriosis: danazol is indicated for use in the treatment of endometriosis amenable to hormonal management. menorrhagia: danazol is indicated for the short-term (up to 6 months) management of primary menorrhagia. fibrocystic disease of the breast: danazol is indicated for the treatment of fibrocystic disease of the breast in both pre- and post-menopausal women. hereditary angioedema: danazol is indicated for the prophylaxis of attacks of hereditary angioedema of a severe or life-threatening nature, in male and female patients.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

viatris limited - danazol 200mg - capsule - 200 mg - active: danazol 200mg excipient: colloidal silicon dioxide erythrosine gelatin   iron oxide red iron oxide yellow lactose lactose monohydrate magnesium stearate microcrystalline cellulose povidone sodium laurilsulfate sodium starch glycolate tekprint black sw-9008 titanium dioxide   - endometriosis: danazol is indicated for use in the treatment of endometriosis amenable to hormonal management. menorrhagia: danazol is indicated for the short-term (up to 6 months) management of primary menorrhagia. fibrocystic disease of the breast: danazol is indicated for the treatment of fibrocystic disease of the breast in both pre- and post-menopausal women. hereditary angioedema: danazol is indicated for the prophylaxis of attacks of hereditary angioedema of a severe or life-threatening nature, in male and female patients.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - methotrexate 20 mg/ml - injection with diluent - 20 mg/ml - active: methotrexate 20 mg/ml excipient: sodium chloride sodium hydroxide water for injection - - active rheumatoid arthritis in adult patients where treatment with disease modifying antirheumatic drugs (dmards) is indicated. - polyarthritic forms of severe, active juvenile idiopathic arthritis (jia) when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate - severe forms of psoriasis vulgaris, particularly of the plaque type, which cannot be sufficiently treated with conventional therapy such as phototherapy, puva, and retinoids, and severe psoriatic arthritis.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methotrexate 10mg (11.11 mg with 10% manufacturing overage);  ; methotrexate 10mg (11.11 mg with 10% manufacturing overage) - tablet - 10 mg - active: methotrexate 10mg (11.11 mg with 10% manufacturing overage)   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose polysorbate 80 starch active: methotrexate 10mg (11.11 mg with 10% manufacturing overage) excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose polysorbate 80 starch - treatment of breast cancer, gestational choriocarcinoma, and in patients with chorioadenoma destruens and hydatidiform mole. palliation of acute and subacute lymphocytic leukaemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukaemias. in combination with corticosteroids, methoblastin may be used for induction of remission. the drug is now most commonly used for the maintenance of induced remissions. methoblastin is also effective in the treatment of the advanced states (iii and iv, peters staging system) of lymphosarcoma, particularly in children and in advanced cases of mycosis fungoides.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methotrexate 2.5mg (2.78 mg with 10% manufacturing overage);   - tablet - 2.5 mg - active: methotrexate 2.5mg (2.78 mg with 10% manufacturing overage)   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose polysorbate 80 starch - treatment of breast cancer, gestational choriocarcinoma, and in patients with chorioadenoma destruens and hydatidiform mole. palliation of acute and subacute lymphocytic leukaemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukaemias. in combination with corticosteroids, methoblastin may be used for induction of remission. the drug is now most commonly used for the maintenance of induced remissions. methoblastin is also effective in the treatment of the advanced states (iii and iv, peters staging system) of lymphosarcoma, particularly in children and in advanced cases of mycosis fungoides.

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - piretanide; ramipril - tablet - 5/6 milligram(s) - ace inhibitors and diuretics; ramipril and diuretics

Singapoo - Kiingereza - HSA (Health Sciences Authority)

pfizer private limited - methylprednisolone sodium succinate eqv methylprednisolone - injection, powder, for solution - 500 mg/8 ml - methylprednisolone sodium succinate eqv methylprednisolone 500 mg/8 ml